Home/Hedge Fund Intelligence/IDEAYA Biosciences, Inc.
Nasdaq: IDYAStockForm 13F30 Jun 2026

Hedge funds that hold IDEAYA Biosciences, Inc. Nasdaq: IDYA

CUSIP 45166A102 · who reports it, how much, and how much it matters to them

29 of the 720 hedge fund managers we track reported shares of IDEAYA Biosciences, Inc. (Nasdaq: IDYA) on Form 13F for 30 June 2026. Between them they reported USD 584m. The largest position belongs to Baker Bros. Advisors, at USD 187m. The manager with the most riding on it is Logos Global Management, where it is 4.8% of the reported book.

Managers reporting it29of 720 we track
Value they reportUSD 584mshares only, 30 Jun 2026
Funds they run484with a file on PPLI.com
Largest positionUSD 187mBaker Bros. Advisors
Typical weight0.1%median share of a manager's book
Heaviest weight4.8%Logos Global Management

Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated

Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.

13F
What this page is

A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.

Who holds it

29 managers, USD 584m between them

Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.

Every manager that reports IDEAYA Biosciences, Inc., largest position first

The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.

#ManagerValue reportedShare of its book
1Baker Bros. Advisors2 funds on PPLI.comUSD 187m0.9%
2Logos Global Management1 fund on PPLI.comUSD 112m4.8%
3Adage Capital Management1 fund on PPLI.comUSD 101m0.1%
4Sofinnova Investments1 fund on PPLI.comUSD 34m1.8%
5Redmile Group10 funds on PPLI.comUSD 24m1.6%
6Dafna Capital Management6 funds on PPLI.comUSD 19m3.5%
7Sio Capital Management4 funds on PPLI.comUSD 18m3.0%
8Walleye Capital8 funds on PPLI.comUSD 14m0.1%
9RTW Investments2 funds on PPLI.comUSD 14m0.1%
10Citadel Advisors32 funds on PPLI.comUSD 11m0.0%
11Balyasny Asset Management25 funds on PPLI.comUSD 11m0.0%
12Burkehill Global Management5 funds on PPLI.comUSD 7.5m0.3%
13Sphera Funds Management1 fund on PPLI.comUSD 7.3m1.0%
14Verition Fund Management3 funds on PPLI.comUSD 6.9m0.0%
15Platinum Investment Management11 funds on PPLI.comUSD 5.2m1.3%
16Ally Bridge Group (Ny)3 funds on PPLI.comUSD 2.5m2.2%
17Atom Investors1 fund on PPLI.comUSD 2m0.2%
18Tudor Investment Corporation10 funds on PPLI.comUSD 1.7m0.0%
19Two Sigma Investments35 funds on PPLI.comUSD 1.5m0.0%
20Squarepoint Ops7 funds on PPLI.comUSD 940,0000.0%
21Lighthouse Investment Partners190 funds on PPLI.comUSD 932,0000.0%
22D. E. Shaw & Co.15 funds on PPLI.comUSD 774,0000.0%
23Millennium Management6 funds on PPLI.comUSD 391,0000.0%
24Neo Ivy Capital Management1 fund on PPLI.comUSD 380,0000.1%
25Magnetar Financial93 funds on PPLI.comUSD 211,0000.0%
26Verdad Advisers6 funds on PPLI.comUSD 201,0000.2%
27Freestone Grove Partners1 fund on PPLI.comUSD 141,0000.0%
28Aquatic Capital Management3 funds on PPLI.comUSD 51,9540.0%
29The Quarry1 fund on PPLI.comUSD 5,6650.0%
Next: where it matters most
Where it matters most

For Logos Global Management it is 4.8% of the book

A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.

#ManagerValue reportedShare of its book
1Logos Global ManagementUSD 112m4.8%
2Dafna Capital ManagementUSD 19m3.5%
3Sio Capital ManagementUSD 18m3.0%
4Ally Bridge Group (Ny)USD 2.5m2.2%
5Sofinnova InvestmentsUSD 34m1.8%
6Redmile GroupUSD 24m1.6%
7Platinum Investment ManagementUSD 5.2m1.3%
8Sphera Funds ManagementUSD 7.3m1.0%
9Baker Bros. AdvisorsUSD 187m0.9%
10Burkehill Global ManagementUSD 7.5m0.3%
Next: how to read this
How to read this

What a 13F list can and cannot tell you

  • It is the manager's filing, not a fund's. Form 13F covers every account a firm runs. We cannot say which of its funds holds the shares.
  • It is a snapshot. The list shows the last day of the quarter. A manager may have bought or sold since, and trading inside the quarter leaves no trace.
  • It shows one side. Short positions, swaps and shares listed outside the United States are not reported, so a manager on this list may be hedged or net short.
  • It covers the managers we track. Our coverage is 720 managers of hedge and private funds. Banks, index funds and other institutions that file Form 13F are not counted here.
Next: questions
Questions

Questions about who holds IDEAYA Biosciences, Inc.

What is the ticker symbol of IDEAYA Biosciences, Inc.?

IDEAYA Biosciences, Inc. trades under the symbol IDYA on the Nasdaq. Its CUSIP, the code used on Form 13F, is 45166A102.

Which hedge funds own IDEAYA Biosciences, Inc. (Nasdaq: IDYA)?

29 of the 720 hedge fund managers PPLI.com tracks reported IDEAYA Biosciences, Inc. shares on Form 13F for 30 June 2026. The largest reported positions were held by Baker Bros. Advisors (USD 187m), Logos Global Management (USD 112m), Adage Capital Management (USD 101m), Sofinnova Investments (USD 34m) and Redmile Group (USD 24m).

How many hedge funds hold IDEAYA Biosciences, Inc.?

29 managers in our coverage reported it, and between them they run 484 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.

Which manager has the most riding on IDEAYA Biosciences, Inc.?

Logos Global Management, where the position was 4.8% of the reported 13F book at 30 June 2026.

Does this show who is short IDEAYA Biosciences, Inc.?

No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.

Important information

Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with IDEAYA Biosciences, Inc. or with the managers listed.

Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.

Private consultation →
Step 1 of 2

Tell us about yourself

Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.

✦Research assistant
✦PPLI.comResearch assistant
Explore PPLI questions and suitability factors
Ask a general question about PPLI, or explore the factors that affect suitability. Treat the answer as a starting point and check the linked sources.
Use the research with your own tax, legal and insurance advisers.
Preparing an answer
AI assistant. Educational information only. It does not determine eligibility or provide personal tax, legal, investment or insurance advice.